Published Articles & Presentations

Published Articles & Presentations

The information in our publications and presentations should be considered accurate only as of the date of the publications or presentations. We disclaim any obligation to supplement or update the information in these publications and presentations.

To learn more about our innovative technology:
The Upper Nasal Space—A Novel Delivery Route Ideal for Central Nervous System Drugs

John Hoekman, Sutapa Ray, Sheena K Aurora, and Stephen B Shrewsbury Abstract: Solid oral dosage forms account for up to 75% of prescriptions, but their effectiveness may be limited in some patients, and inappropriate for others. While injectable formulations may…

READ MORE

The SNAP 101 Double-Blind, Placebo/Active-Controlled, Safety, Pharmacokinetic, and Pharmacodynamic Study of INP105 (Nasal Olanzapine) in Healthy Adults

Stephen B. Shrewsbury, MB, ChB; Jasna Hocevar-Trnka, MD; Kelsey H. Satterly, PhD; Karen L. Craig, PhD; Jason D. Lickliter, MBBS; and John Hoekman, PhD Full manuscript can be accessed here: https://www.psychiatrist.com/JCP/article/Pages/2020/v81/19m13086.aspx Objective: INP105 is a drug-device combination of olanzapine and technology…

READ MORE

Dihydroergotamine (DHE) – Then and Now: A Narrative Review

November 17, 2019 Stephen D. Silberstein, MD; Stephen B. Shrewsbury, MBChB; John Hoekman, PhD Objective: To provide a narrative review of clinical development programs for non-oral, non-injectable formulations of dihydroergotamine (DHE) for the treatment of migraine. Background: Dihydroergotamine was one…

READ MORE